Trey Andrews Associate

Trey's practice focuses on handling complex healthcare transactional, regulatory, and enforcement matters for healthcare providers and private equity firms and lenders in the healthcare industry.

Trey works with hospitals, management services organizations (MSOs), physician group practices, imaging centers, drug and device manufacturers and distributors, infusion therapy centers and service providers, home health agencies, durable medical equipment (DME) and nutrition companies, eye care centers, telehealth providers, in-vitro fertilization and reproductive services clinics, and vision insurance plans.  In this capacity, he has assisted clients with a broad range of healthcare regulatory matters, including, facility and provider licensing, operational and compliance issues, Medicare and Medicaid participation, and drug distribution and supply chain issues.  Additionally, he has conducted risk assessments on compliance programs, and advised companies on government and internal investigations and responding to subpoenas and civil investigative demands.   

Trey also represents companies, private equity firms, investment banking and financial services firms, and healthcare technology firms in major acquisitions, investments, and divestitures in the healthcare industry.  In this capacity, he has conducted healthcare regulatory due diligence, assisted with change of ownership (CHOW) issues before state pharmacy boards, provided guidance on transaction structures, and facilitated operational integration post-closing.    

Additionally, he routinely provides guidance on the following:

  1. Federal and state anti-kickback statutes
  2. Federal and state referral and fee-splitting prohibitions
  3. Federal False Claims Act
  4. Corporate practice of medicine
  5. HIPAA Privacy and Security Rules and the HITECH Act
  6. Federal and state privacy and information security laws

Prior to joining McGuireWoods, Trey practiced healthcare regulatory and transactional law in the San Francisco office of an international law firm.He also worked in the General Counsel’s office of AdvaMed, a global trade association representing advanced medical technology and device manufacturers, where he concentrated on international anti-corruption issues and developing industry codes of ethics and compliance tools.


Represented international buyer as healthcare regulatory counsel in connection with its acquisition of multiple in-vitro fertilization and reproductive services clinics, including providing guidance on structuring transaction within compliance of the California corporate practice of medicine prohibition with use of the management services organization model.

Represented a global specialty pharmaceutical distributor as healthcare regulatory counsel in its acquisition of a national outpatient infusion therapy and healthcare management company, specializing in the turnkey management of physician office-based infusion centers.

Represented a global healthcare IT medical-surgical supplies and pharmaceutical distributor as healthcare regulatory counsel in its acquisition of a national cancer treatment facility network.

Represented a global investment management firm as healthcare regulatory counsel in connection with its successful investment in a leading LASIK eye surgery company.

Represented a global investment banking and financial services firm on healthcare regulatory and fraud and abuse issues in connection with its successful investment in a national home health, palliative care and hospice provider.

Represented private equity firm as healthcare regulatory counsel in its acquisition of a leading national eye care center and vision insurance plan.

Represented global pharmaceutical distributor as healthcare regulatory counsel in connection with the acquisition of multiple drug wholesale distributors, third party logistics (3PL) providers, medical billing companies, and infusion therapy centers.

Assisted national drug distributor with licensure gap analysis of all U.S. based drug wholesale distributor and 3PL facilities.

Represented private equity firm in connection with negotiating and updating its credit agreement in connection with acquisitions and divestitures of its portfolio healthcare companies.

Provided healthcare regulatory counsel and assistance to a multi-national provider of healthcare products and services with its acquisition of a durable medical equipment supply company specializing in urological products.

Represented a national home care company, a portfolio company of a national healthcare focused private equity firm, as healthcare regulatory counsel on the acquisition of two enteral nutrition and DME companies.

Represented radiology group in sale of multiple imaging centers to regional health system and provided advice on professional services and management agreements related to the post-closing operation of the imaging centers and hospital radiology departments.

Counsel healthcare and life sciences companies on forming and restructuring joint ventures and management services organizations (MSOs).

Advised pharmaceutical and medical device manufacturers on risk under the federal Anti-Kickback Statute for proposed pilot programs, value-added services programs, and new product marketing initiatives.

Acted as outside healthcare regulatory counsel to several national telehealth and telemedicine companies, including providing guidance on the deployment telemedicine and teleradiology services.

Conducted internal investigations for health systems in relation to compliance with policies, procedures, and applicable regulations.

Represented clients in government investigations defense related to alleged False Claims Act violations, appropriate physician supervision requirements, alleged violations of the minimum medical loss ratio, and violations of the federal Anti-Kickback Statute.

  • The George Washington University Law School, JD, 2013
  • The University of North Carolina at Wilmington, BS, Biology, 2007
Member, North Carolina Bar Association
  • California
  • North Carolina

The rules of professional conduct in some jurisdictions require disclosure of selection methodology for certain public accolades and recognitions. Click here to view available selection methodologies.

Selected for inclusion in Best Lawyers: Ones to Watch, Health Care Law, 2021

Back to top